Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors

[1]  M. Melachrinou,et al.  Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients' survival. , 2007, Pathology, research and practice.

[2]  L. Donehower,et al.  The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. , 2007, Blood.

[3]  R. DePinho,et al.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.

[4]  A. Iwama,et al.  Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice , 2006, The Journal of experimental medicine.

[5]  S. Morrison,et al.  Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. , 2006, Blood.

[6]  M. Clarke,et al.  Stem Cells and Cancer: Two Faces of Eve , 2006, Cell.

[7]  S. Morrison,et al.  SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. , 2006, Blood.

[8]  H. Lodish,et al.  Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells , 2006, Nature Medicine.

[9]  B. Sorrentino,et al.  A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. , 2005, Blood.

[10]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[11]  S. Morrison,et al.  Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. , 2005, Genes & development.

[12]  H. Lodish,et al.  Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. , 2005, Blood.

[13]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[14]  H. Lodish,et al.  Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. , 2004, Blood.

[15]  S. Morrison,et al.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.

[16]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[17]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[18]  F. Bootz,et al.  INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck , 2002, Virchows Archiv.

[19]  I. Weissman,et al.  A Genetic Determinant That Specifically Regulates the Frequency of Hematopoietic Stem Cells1 , 2002, The Journal of Immunology.

[20]  I. Weissman,et al.  Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Jacobsen,et al.  Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. , 2001, Immunity.

[22]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[23]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[24]  Marilyn Plant,et al.  The two faces of Eve , 1995 .

[25]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[26]  L. Liotta,et al.  Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  J. Adolfsson,et al.  Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  J. Herman,et al.  Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. , 2000, Cancer research.